C. Wild

The Role of Chemokines in Cervical Cancers

N. Ditsch, U. Jeschke, C. Dannecker, 2021, Medicina.

MTA1 as negative prognostic marker in vulvar carcinoma

G. Wanka, U. Jeschke, C. Kuhn, 2023, Journal of Cancer Research and Clinical Oncology.

Five years of EMA-approved systemic cancer therapies for solid tumours d a comparison of two thresholds for meaningful clinical benefit

C. Booth, R. Emprechtinger, S. Wolf, 2017 .

Health-related quality of life in patients with non-functioning pituitary adenoma: a special focus on hydrocortisone replacement dose

G. Stalla, M. Auer, M. Stieg, 2020, Quality of Life Research.

Sleep patterns in patients treated for non-secreting intra- and parasellar tumors: A self-report case-control study

G. Stalla, M. Auer, C. Jung-Sievers, 2022, Frontiers in Endocrinology.

The programmed cell death protein 1 (PD1) and the programmed cell death ligand 1 (PD-L1) are significantly downregulated on macrophages and Hofbauer cells in the placenta of preeclampsia patients.

N. Ditsch, U. Jeschke, C. Kuhn, 2023, Journal of reproductive immunology.

Expression of Progesterone Receptor A as an Independent Negative Prognosticator for Cervical Cancer

U. Jeschke, D. Mayr, S. Mahner, 2023, International journal of molecular sciences.